Colonic Mucosal Microbiota and Association of Bacterial Taxa with the Expression of Host Antimicrobial Peptides in Pediatric Ulcerative Colitis
Open Access
- 22 August 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (17) , 6044
Abstract
Inflammatory bowel diseases (IBD), ulcerative colitis (UC) and Crohn’s disease (CD), are chronic debilitating disorders of unknown etiology. Over 200 genetic risk loci are associated with IBD, highlighting a key role for immunological and epithelial barrier functions. Environmental factors account for the growing incidence of IBD, and microbiota are considered as an important contributor. Microbiota dysbiosis can lead to a loss of tolerogenic immune effects and initiate or exacerbate inflammation. We aimed to study colonic mucosal microbiota and the expression of selected host genes in pediatric UC. We used high-throughput 16S rDNA sequencing to profile microbiota in colonic biopsies of pediatric UC patients (n = 26) and non-IBD controls (n = 27). The expression of 13 genes, including five for antimicrobial peptides, in parallel biopsies was assessed with qRT-PCR. The composition of microbiota between UC and non-IBD differed significantly (PCoA, p = 0.001). UC children had a decrease in Bacteroidetes and an increase in several family-level taxa including Peptostreptococcaceae and Enterobacteriaceae, which correlated negatively with the expression of antimicrobial peptides REG3G and DEFB1, respectively. Enterobacteriaceae correlated positively with the expression siderophore binding protein LCN2 and Betaproteobacteria negatively with DEFB4A expression. The results indicate that reciprocal interaction of epithelial microbiota and defense mechanisms play a role in UC.Keywords
Funding Information
- Research Council of Finland (323156, 316338)
- Sigrid Juséliuksen Säätiö (Senior Research Fellow)
- Helsingin Yliopisto (A three-year grant)
- Lastentautien Tutkimussäätiö (160048)
- Varsinais-Suomen Sairaanhoitopiiri (EVO 13004)
This publication has 41 references indexed in Scilit:
- The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet Gastroenterology & Hepatology, 2020
- Microbiota and mucosal defense in IBD: an updateExpert Review of Gastroenterology & Hepatology, 2019
- Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort—An Epi-IBD StudyJournal of Crohn's and Colitis, 2018
- DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With OutcomeGastroenterology, 2018
- Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel diseaseNature Genetics, 2017
- Increased expression of CXCL16, a bacterial scavenger receptor, in the colon of children with ulcerative colitisJournal of Crohn's and Colitis, 2014
- Antimicrobial peptides and gut microbiota in homeostasis and pathologyEMBO Molecular Medicine, 2013
- The gut microbiota in IBDNature Reviews Gastroenterology & Hepatology, 2012
- IBD—what role do Proteobacteria play?Nature Reviews Gastroenterology & Hepatology, 2012
- Genetics and pathogenesis of inflammatory bowel diseaseNature, 2011